What happens next in GLP-1 — and when.

Get the briefing

What moved in the GLP‑1 field, in your inbox.

@glp1briefing

Indications › Polycystic ovary syndrome › liraglutide

liraglutide in polycystic ovary syndrome

liraglutide is not approved in the US for polycystic ovary syndrome, and has 14 trials on file here in this condition. All 14 are phase 3 or later. The next scheduled result is 2029-05-30. Being studied in a condition is not the same as being approved for it; most such programmes end without an approval.

14 registered trials study liraglutide (Victoza, Xultophy, Saxenda) in polycystic ovary syndrome, 1 of them still active. None has a scheduled reporting date on file.

Trials on file
14
Active
1
Active phase 3
0
Participants in active trials
890
Sponsors
8
Scheduled readouts
0

All trials on file

Every registered trial of liraglutide grouped under polycystic ovary syndrome, largest first. Grouping follows the registry’s own condition wording.

TrialStatusPhaseSponsor
Liraglutide Treatment in Obese Infertile PCOS Women
NCT06742710
RecruitingP4Peking University Third Hospital
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
NCT05952882
UnknownP3Mỹ Đức Hospital
Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
NCT05965908
CompletedP3Beni-Suef University
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
NCT03480022
CompletedP3Woman's
LIPT - Liraglutide in Polycystic Ovary Syndrome
NCT02073929
CompletedP4Jens Faber
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
NCT03151005
CompletedP4Xinqiao Hospital of Chongqing
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
NCT02187250
CompletedP4University Medical Centre Ljubljana
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
NCT02483299
CompletedP4University Medical Centre Ljubljana
Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
NCT01911468
CompletedP4University Medical Centre Ljubljana
Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients
NCT03034941
CompletedP4University Medical Centre Ljubljana
Polycystic Ovary Syndrome and Liraglutide
NCT01899430
CompletedP4University Medical Centre Ljubljana
Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
NCT02909933
CompletedP4University Medical Centre Ljubljana
The Effect of a Liraglutide on IVF in Obese PCOS
NCT03353948
CompletedP4University Medical Centre Ljubljana
The Gut Microbiome in Women With Polycystic Ovary Syndrome
NCT03642600
CompletedP4Universitaire Ziekenhuizen KU Leuven

See the full record for liraglutide, or every molecule being studied in polycystic ovary syndrome. These are registered trials, nothing more. Most drugs tested in a new condition never get approved for it, and plenty of these will report nothing useful.